Remission of severe cold agglutinin disease after Rituximab therapy.

Aged; Anemia, Hemolytic, Autoimmune/drug therapy/physiopathology; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents/therapeutic use; Female; Humans; Remission Induction

Disciplines :

Anesthesia & intensive care

Author, co-author :

LAYIOS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs

Van Den Neste, E.

Jost, E.

Deneys, V.

Scheiff, J. M.

Ferrant, A.

Language :

English

Title :

Remission of severe cold agglutinin disease after Rituximab therapy.

Publication date :

2001

Journal title :

Leukemia

ISSN :

0887-6924

eISSN :

1476-5551

Publisher :

Nature Publishing Group, London, United Kingdom

Volume :

Issue :

Pages :

187-8

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 09 February 2012

Statistics

Number of views

78 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Maloney D.G., Grillo-Lopez A.J., White C.A., Bodkin D., Schilder R.J., Neidhart J.A., Janakiraman N., Foo K.A., Liles T.M., Dallaire B.K., Wey K., Royston I., Davis T., Levy R. (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188-2195.
Byrd J.C., White C.A., Link B., Lucas M.S., Velasquez W.S., Rosenberg J., Grillo-Lopez A.J. (1999) Rituximab therapy in Waldenstrom's macroglobulinemia: Preliminary evidence of clinical activity. Ann Oncol 10:1525-1527.
O'Connor B.M., Clifford J.M., Lawrence W.D., Logue G.L. (1989) Alpha-interferon for severe cold agglutinin disease. Ann Intern Med 111:255-256.
Lee E.J., Kueck B. (1998) Rituxan in the treatment of cold agglutinin disease. Blood 92:3490-3491.
Zaja F., Russo D., Fuga G., Patriarca F., Ermacora A., Baccarani M. (1999) Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 84:1157-1158.
Levine T.D., Pestronk A. (1999) IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology 52:1701-1704.
Venugopal P., Sivaraman S., Huang X., Chopra H.K., O'Brien T., Jajeh A., Preisler H.D. (1998) Upregulation of CD20 expression in chronic lymphocytic leukemia (CLL) cells by in vitro exposure to cytokines. Blood , (Abstr. 1009); 92:247a.
Bungard S., Flieger D., Schweitzer S., Sauerbruch T., Spengler U. (1998) The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. Cancer Immunol Immunother 46:213-220.